Three years of follow-up from the COMISAIR study has found that glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than
As reported by Business Insider in late August, Dexcom announced that it had acquired TypeZero Technologies, Inc. TypeZero’s offering includes the inControl diabetes management system,
In this issue we look at what you need to know about coeliac disease and gluten intolerance. There’s news (from p.4) about Dexcom buying TypeZero
In a survey of Britons living with diabetes, 19% claimed they had faced disciplinary action at some point for missing work as a result of
Verily and Dexcom are developing miniaturized continuous glucose monitors (CGM) to help people with Type 2 diabetes better manage the condition. Verily and Dexcom are
Dexcom has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up. John Lister, Dexcom’s General Manager for
The next generation of Dexcom sensor builds on the company’s existing CGM capability. It is being argued that Dexcom’s latest G6 sensors could convert CGM
EDITOR’S NOTE: When I spoke to Gavin Griffiths, also known as the DiAthlete, he had completed 16 marathons and had nine more to do before
The US Patent Office Patent Trial and Appeal Board recently ruled to uphold the validity of WaveForm Technologies Inc. patents in the emerging field of
Animas UK and Ireland has confirmed that it is withdrawing from the insulin pump supply market and is presently working through a transition period with
